跳至主要内容
临床试验/TCTR20240512004
TCTR20240512004招募中1 期

The Effect of intravenous Ascorbic acid combined with intravenous tranexamic acid in Anemia of Hemodialysis patients ; A Randomized Controlled Trial

Buriram Hostpital, Thailand0 个研究点目标入组 40 人开始时间: 2024年5月12日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Kidney failure patients undergoing hemodialysis treatment with hemodialysis who have anemia from inflammatory processes in the body with a hemoglobin level less than or equal to 11 g/dl, a serum ferritin level greater than 800 ng/ml, and a serum transferrin saturation greater than or equal to 40%.

排除标准

  • 1) Patients with end stage kidney disease receiving kidney replacement therapy with hemodialysis who have a history of epilepsy. or have had a history of brain surgery
  • 2) Patients with urinary tract stone problems
  • 3) Patients who are allergic to vitamin C injectable form and allergic to tranexamic acid.
  • 4) Patients who have received iron injections within the past 2 months.
  • 5) Patients who refuse to participate in the study

研究者

发起方
Buriram Hostpital, Thailand

相似试验